Concepedia

Ahmed Sawas

AS

27

Publications

1.5K

Citations

16

H-Index

2007

Active since

Affiliations

Columbia University Irving Medical Center(Current)

Columbia University

Memorial Sloan Kettering Cancer Center

Mayo Clinic in Arizona

Dana-Farber Cancer Institute

Ahmed Sawas is an author at Columbia University Irving Medical Center specializing in medicine, pathology, and oncology.

ORCID

Top concepts

Publications per year

2007–2024

27

Publications

27

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

Ann S. LaCasce, R. Gregory Bociek, Ahmed Sawas et al. · Blood · 2018 · 246 citations · Full text

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Stephen M. Ansell, Michael B. Maris, Alexander M. Lesokhin et al. · Clinical Cancer Research · 2021 · 183 citations · Full text

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma

Jennifer E. Amengual, Renee Lichtenstein, Jennifer Kimberly Lue et al. · Blood · 2017 · 128 citations · Full text

Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study

Owen A. O’Connor, Lorenzo Falchi, Jennifer Kimberly Lue et al. · Blood · 2019 · 127 citations · Full text

Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial

Owen A. O’Connor, Jennifer Kimberly Lue, Ahmed Sawas et al. · The Lancet Oncology · 2017 · 113 citations · Full text

, , +5

Rows per page

1–5 of 27